NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Daniel M Franz
Loma Linda University - Loma Linda / United States
Others
AD Scientific Index ID: 5357846
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Daniel M Franz's MOST POPULAR ARTICLES
1-)
Effects of amphetamine on sensorimotor gating and neurocognition in antipsychotic-medicated schizophrenia patientsNR Swerdlow, SG Bhakta, JA Talledo, DM Franz, EL Hughes, BK Rana, ...Neuropsychopharmacology 43 (4), 708-717, 2018192018
2-)
Early Auditory Information Processing in Schizophrenia as a Therapeutic Target: Preliminary Dose-Response Findings With AmphetamineN Swerdlow, D Franz, L Benster, J Talledo, S Bhakta, G LightNeuropsychopharmacology 43, S478-S478, 201822018
3-)
72. One Pill Can Enhance Auditory Information Processing and Learning in Schizophrenia Patients: Should We Rethink the Way We’re Approaching Therapeutic Development for …N Swerdlow, S Bhakta, J Talledo, D Franz, B Rana, G LightBiological Psychiatry 83 (9), S29-S30, 20182018
4-)
Effect of Tolcapone on Cognitive Control in Chronic Psychotic Disorder PatientsS Bhakta, G Light, J Talledo, D Franz, J Young, N SwerdlowNEUROPSYCHOPHARMACOLOGY 43, S233-S234, 20172017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept